Multiple metastases but not all accessible





Introduction


Metastatic brain tumors are the most common type of brain tumors in adults, in which approximately 30% of cancer patients will develop metastatic brain tumors. , This number is expected to rise as systemic disease control continues to improve. , However, despite improvement in cancer diagnosis and treatment, the median ­survival ­remains 4 months, with 2-year survival rates less than 6%. The current treatment paradigm for patients with metastatic brain tumors is heavily dependent on ­individual ­patient characteristics, including age, functional status, disease control, and tumor molecular characteristics, among others. , , Surgery has been shown to play an important role in certain circumstances, namely for ­lesions causing significant neurologic symptoms, as tumor resection remains the only effective method in providing immediate relief of mass effect. This usually ­applies to large tumors (>3 cm), as well as tumors causing mass effect, neurologic deficits, and seizures. A relative contraindication to surgery is the presence of multiple ­lesions, as surgery may not improve the natural history of the individual’s disease, and there may be significant morbidity associated with accessing and resecting some of the lesions with little added benefit. In cases with multiple brain tumors in which there is a large dominant lesion, surgical resection of the more symptomatic lesion may be warranted. In this chapter, we present a case of multiple brain lesions in which some may not be surgically accessible without inherent risks.



Example case


Chief complaint: headache, imbalance, and speaking difficulties


History of present illness


A 35-year-old, right-handed woman with a history of metastatic breast cancer status post bilateral mastectomy and local radiation therapy and chemotherapy who presented with progressive headaches, imbalance, and speaking difficulties. These headaches are diffuse, bifrontal, and exacerbated with straining. She also complained of imbalance and decreased coordination with both hands but denies any focal weakness. She also complained of difficulty getting her words out. These symptoms have been going on for the past week. She saw her oncologist, and imaging was done ( Fig. 35.1 ).




  • Medications : Lisinopril.



  • Allergies : No known drug allergies.



  • Past medical and surgical history : Metastatic breast adenocarcinoma status bilateral mastectomy.



  • Family history : Strong family of history of breast cancer.



  • Social history: Teacher, no smoking or alcohol history.



  • Physical examination : Awake, alert, oriented to person, place, and time; Language: dysarthric and slowness with speech; Cranial nerves II to XII intact; No drift, moves all extremities with full strength; Cerebellar: right > left finger-to-nose dysmetria.



  • Computed tomography chest/abdomen/pelvis : Two small lung nodules and one liver lesion suspicious for metastatic disease.




Fig. 35.1


Preoperative magnetic resonance imaging. (A) T1 axial image with gadolinium contrast through the middle frontal gyrus; (B) T1 axial image with gadolinium contrast through the superior frontal gyrus; (C) T1 axial image with gadolinium contrast through the traverse sinus; (D) T1 sagittal image with gadolinium contrast demonstrating three metastatic lesions involving the left middle frontal gyrus, the left precentral gyrus at the level of the hand, and the right superior cerebellar hemisphere.




























































































































































Miguel A. Arraez, MD, PhD, Carlos Haya University, Hospital Malaga, Spain Mark Bernstein, MD, University of Toronto, Toronto, Canada Michael Lim, MD, Stanford University School of Medicine, Stanford, CA, United States Gabriel Zada, MD, University of Southern California, Los Angeles, CA, United States
Preoperative
Additional tests requested Oncology evaluation Neuropsychological assessment fMRI Full-body PET
Physical therapy
Radiation Oncology/oncology evaluation
Surgical approach selected Right suboccipital +/– left frontal craniotomy Right posterior fossa and left frontal craniotomies if symptoms do not respond with steroids, SRS for left paracentral lesion Right suboccipital craniotomy and left frontal craniotomy for tumor with IOM SRS for all three lesions
Anatomic corridor Right cerebellar hemisphere Right cerebellar hemisphere and left frontal Right cerebellar hemisphere and left frontal SRS
Goal of surgery Gross total resection of posterior fossa lesion Gross total resection of both lesions Maintaining quality of life Tumor control
Perioperative
Positioning Right park bench Right park bench followed by left supine Prone followed by left supine Leksell frame
Surgical equipment Surgical navigation
Surgical microscope with 5-ALA
Ultrasonic aspirator
Surgical navigation
Surgical microscope
IOM (BAERs)
IOM (SSEP) Gamma knife
Medications Steroids Steroids Steroids
Mannitol
Hyperventilation
Steroids
Anatomic considerations Transverse sinus, tentorium, cerebellar surface Cerebellar lesion: transverse sinus
Frontal lesion: speech cortex
Cerebellar lesion: swelling
Frontal lesion: speech cortex
Cerebellar lesion: swelling
Frontal lesion: speech and motor cortex
Complications feared with approach chosen Injury to transverse sinus and cerebellum Neurologic worsening, language dysfunction Language dysfunction Language dysfunction, motor deficit
Intraoperative
Anesthesia General General General Conscious sedation
Skin incision Right paramedian Cerebellar lesion: curvilinear
Frontal lesion: linear
Cerebellar lesion: linear paramedian
Frontal lesion: linear
None
Bone opening Right suboccipital Cerebellar lesion: right posterior fossa up to transverse sinus above foramen magnum
Frontal lesion: left frontal
Cerebellar lesion: overlying lesion
Frontal lesion: left MFG
None
Brain exposure Cerebellum overlying lesion Cerebellar lesion: right cerebellar hemisphere up to transverse sinus
Frontal lesion: left MFG
Cerebellar lesion: overlying lesion
Frontal lesion: left MFG
None
Method of resection Right suboccipital craniotomy based on navigation, dural opening and reflected toward transverse sinus, microsurgical intralesional removal with ultrasonic aspirator, watertight dural closure Cerebellar lesion first, suboccipital craniectomy with bur holes and rongeurs up to transverse sinus but maintaining foramen magnum based on navigation, dural opening based on transverse sinus, resection with microscopic visualization, dural closure with dural substitute if necessary, cranioplasty with mesh. Head refixed for left frontal lesion, craniotomy based on navigation, dural opening, microsurgical removal of tumor Cerebellar lesion first, suboccipital craniotomy guided by navigation, cruciate dural opening, corticectomy over most superficial aspect of tumor, internal debulking of tumor, mobilize capsule, gross total resection. Head refixed, left MFG craniotomy based on navigation, cruciate dural opening, en bloc resection None
Complication avoidance Awareness of transverse sinus, intralesional resection Cerebellar lesion: large opening
Frontal lesion: access lesion where lesion comes to surface
Cerebellar lesion: opening confined to tumor
Frontal lesion: en bloc resection
Avoidance of surgery
Postoperative
Admission ICU Floor ICU Home
Postoperative complications feared Cerebellar edema Cerebellar edema, language dysfunction CSF leak, language dysfunction Peritumoral edema, radiation effect, language dysfunction, right-sided weakness, hydrocephalus
Follow-up testing CT within 24 hours after surgery
MRI within 72 hours after surgery
CT within 24 hours after surgery
MRI prior to radiation
MRI within 48 hours after surgery MRI 2 months after SRS
Follow-up visits 7 days after surgery 14 days after surgery 14 days after surgery 14 days after surgery
Adjuvant therapies recommended SRS for left frontal and perirolandic lesions SRS for all resected and nonresected lesions SRS boost for all resected and nonresected lesions or WBRT Chemotherapy per oncology

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 15, 2025 | Posted by in NEUROSURGERY | Comments Off on Multiple metastases but not all accessible

Full access? Get Clinical Tree

Get Clinical Tree app for offline access